Incannex partners with AASM Foundation, sponsors junior investigator sleep apnea grant

Incannex Healthcare Inc.

Partnership with AASM Foundation Corporate Recognition Program to support sleep apnea research.
Sponsors a Focused Projects Grant for Junior Investigators in Diagnosis, Management, and Treatment of Sleep Apnea, to be awarded in 2026.
IHL-42X Phase 2 DReAMzz study patient dosing expected within coming months; Phase 3 pathway defined.
Previous milestones: positive Phase 2 results, FDA Fast Track designation, and establishment of Clinical Advisory Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.